Education
About Us
Working with TipRanks
Follow Us
BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
Total Valuation
BioAge Labs, Inc. has a market cap or net worth of $159.89M. The enterprise value is -$140.49M.
Market Cap$159.89M
Enterprise Value-$140.49M
Share Statistics
BioAge Labs, Inc. has 35,850,037 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,850,037
Owned by Insiders13.57%
Owned by Institutions49.32%
Financial Efficiency
BioAge Labs, Inc.’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -23.23%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-23.23%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee0.00
Profits Per Employee-1.15M
Employee Count62
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioAge Labs, Inc. is ―. BioAge Labs, Inc.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.19
Price to FCF―
Price to Operating Cash Flow-2.85
PEG Ratio―
Income Statement
In the last 12 months, BioAge Labs, Inc. had revenue of 0.00 and earned -71.11M in profits. Earnings per share was -6.63.
Revenue0.00
Gross Profit0.00
Operating Income-78.19M
Pretax Income-71.11M
Net Income-71.11M
EBITDA-78.19M
Earnings Per Share (EPS)-6.63
Cash Flow
In the last 12 months, operating cash flow was -57.40M and capital expenditures -916.00K, giving a free cash flow of -58.32M billion.
Operating Cash Flow-57.40M
Free Cash Flow-58.32M
Free Cash Flow per Share-1.63
Dividends & Yields
BioAge Labs, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.44
52-Week Price Change-78.33%
50-Day Moving Average4.44
200-Day Moving Average6.84
Relative Strength Index (RSI)50.65
Average Volume (3m)105.14K
Important Dates
BioAge Labs, Inc. upcoming earnings date is Nov 6, 2025, After Close (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
BioAge Labs, Inc. as a current ratio of 12.86, with Debt / Equity ratio of 2.97%
Current Ratio12.86
Quick Ratio12.86
Debt to Market Cap0.14
Net Debt to EBITDA4.42
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioAge Labs, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioAge Labs, Inc. EV to EBITDA ratio is 3.63, with an EV/FCF ratio of 5.46.
EV to Sales0.00
EV to EBITDA3.63
EV to Free Cash Flow5.46
EV to Operating Cash Flow5.50
Balance Sheet
BioAge Labs, Inc. has $297.30M in cash and marketable securities with $8.75M in debt, giving a net cash position of -$288.55M billion.
Cash & Marketable Securities$297.30M
Total Debt$8.75M
Net Cash-$288.55M
Net Cash Per Share-$8.05
Tangible Book Value Per Share$30.12
Margins
Gross margin is 37.56%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin37.56%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioAge Labs, Inc. is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$5.00
Price Target Upside12.11% Upside
Analyst ConsensusModerate Sell
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―